CureVac N.V (CVAC) Social Stream
CUREVAC NV (CVAC) Price Targets From Analysts
Use the tables below to see what analysts covering CUREVAC NV think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-19 | 3 | $65 | $41 | $53 | $6.7 | 691.04% |
| 2022-01-05 | 3 | $55 | $41 | $48 | $6.7 | 616.42% |
| 2022-01-18 | 4 | $55 | $41 | $49.333 | $6.7 | 636.31% |
| 2022-04-11 | 4 | $52 | $20 | $37.666 | $6.7 | 462.18% |
| 2022-05-09 | 3 | $52 | $17 | $29.666 | $6.7 | 342.78% |
| 2022-05-27 | 3 | $52 | $17 | $29.333 | $6.7 | 337.81% |
| 2022-08-13 | 3 | $52 | $15 | $28.666 | $6.7 | 327.85% |
| 2022-08-19 | 3 | $52 | $15 | $28.333 | $6.7 | 322.88% |
| 2022-09-17 | 3 | $52 | $13 | $27.666 | $6.7 | 312.93% |
| 2022-11-17 | 3 | $34.001 | $13 | $21.667 | $6.7 | 223.39% |
| 2022-11-18 | 3 | $34.001 | $10 | $19 | $6.7 | 183.58% |
| 2023-01-06 | 3 | $34.001 | $9 | $17.667 | $6.7 | 163.69% |
| 2023-02-08 | 3 | $34.001 | $10 | $21.667 | $6.7 | 223.39% |
The Trend in the Analyst Price Target
CVAC's average price target has moved down $45.46 over the prior 19 months.
Over the past 43 weeks, CVAC's average upside potential has been 127.47%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-09 | 3 | 52.000 | 17 | 29.666 | 15.35 | 93.26% |
| 2022-06-15 | 3 | 52.000 | 15 | 28.666 | 13.45 | 113.13% |
| 2022-09-17 | 3 | 52.000 | 13 | 27.666 | 9.57 | 189.09% |
| 2022-11-17 | 3 | 34.001 | 13 | 21.667 | 8.50 | 154.91% |
| 2023-01-06 | 3 | 34.001 | 10 | 21.667 | 8.26 | 162.31% |
CVAC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 2 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
Over the past 29 months, CVAC's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- CUREVAC NV's number of analysts covering the stock is higher than 149.64% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, CUREVAC NV's upside potential (average analyst target price relative to current price) is greater than 1338.08% of them.
- CUREVAC NV's variance in analysts' estimates is lower than -1031.58% of stocks in the large market cap category.
- In terms of how CUREVAC NV fares relative to stocks in the large market cap category, note that its average analyst price target is greater than 272.79% of that group.
In the Pharmaceutical Products industry, MRVI, ABCL, and RVMD are the three stocks most similar to CUREVAC NV regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding CVAC using the data that counts. Try POWR Ratings for free.